This however results in an enigma: Y loss in CD4 + T lymphocytes is associated with increased risk of cancer, yet LOY occurs at relatively low levels in CD4 + T lymphocytes compared with other leukocytes [3, 12, 13]. This evidence concerns the gene CD4 and cancer.